U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06821945) titled 'A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia' on Feb. 06.

Brief Summary: The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Schizophrenia

Intervention: DRUG: BR5402A

Subjects take the investigational products once a day

DRUG: BR5402A-1

Subjects take the investigational products once a day

DRUG: BR5402B

Subjects take the investigational products once a day

DRUG: BR5402B-1

Subjects take the investi...